In a guest post on the Global Health Technologies Coalition’s (GHTC) “Breakthroughs” blog, “Jenny Howell — senior policy and advocacy associate at PATH working with the GHTC — writes about how the government shutdown and budget negotiations in Congress will impact global health research and development (R&D) programs across the federal government,” the blog’s introduction states, adding, “She also provides an update on new legislation that would impact [PEPFAR].” Howell summarizes how the government shutdown is affecting different agencies, and she notes the Senate Foreign Relations Committee’s passage of an amended PEPFAR Stewardship and Oversight Act of 2013. She concludes, “While uncertainty about the impact of the shutdown remains high, the quicker that lawmakers can reach an agreement the less severe the negative effects will be across our nation and around the world. Whatever the outcome, we’ll continue to track the progress and its potential impact on global health R&D” (Lufkin, 10/2).